These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 18000094

  • 1. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
    Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):400-9. PubMed ID: 18000094
    [Abstract] [Full Text] [Related]

  • 2. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 3. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B.
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [Abstract] [Full Text] [Related]

  • 4. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease.
    Gebre-Medhin G, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):775-80. PubMed ID: 10848883
    [Abstract] [Full Text] [Related]

  • 5. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [Abstract] [Full Text] [Related]

  • 6. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
    Villareal DT, Holloszy JO, Kohrt WM.
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916
    [Abstract] [Full Text] [Related]

  • 7. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 8. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
    [Abstract] [Full Text] [Related]

  • 9. DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
    Arlt W, Callies F, Allolio B.
    Endocr Res; 2000 Nov; 26(4):505-11. PubMed ID: 11196420
    [Abstract] [Full Text] [Related]

  • 10. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.
    Rice SP, Agarwal N, Bolusani H, Newcombe R, Scanlon MF, Ludgate M, Rees DA.
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1966-72. PubMed ID: 19318448
    [Abstract] [Full Text] [Related]

  • 11. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 12. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

  • 13. Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.
    Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, Chatterjee VK.
    Eur J Immunol; 2005 Dec; 35(12):3694-703. PubMed ID: 16252254
    [Abstract] [Full Text] [Related]

  • 14. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
    Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R, Weiss EP, Villareal DT, Kohrt WM.
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439
    [Abstract] [Full Text] [Related]

  • 15. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B.
    J Clin Endocrinol Metab; 2001 May; 86(5):1968-72. PubMed ID: 11344193
    [Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone replacement in addison's disease.
    Kim SS, Brody KH.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):96-7. PubMed ID: 11435018
    [Abstract] [Full Text] [Related]

  • 17. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
    Christiansen JJ, Andersen NH, Sørensen KE, Pedersen EM, Bennett P, Andersen M, Christiansen JS, Jørgensen JO, Gravholt CH.
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):426-33. PubMed ID: 17302879
    [Abstract] [Full Text] [Related]

  • 18. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 20. Replacement therapy for Addison's disease: recent developments.
    Løvås K, Husebye ES.
    Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.